DiaMedica Therapeutics Inc. (DMAC) KPIs and segments

DMACNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026Score 6/30

$9.66−0.01 (-0.10%)

Close on Nov 11, 2026Market cap $520.92MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive DiaMedica Therapeutics's business

Coming soon

This tab will track the numbers specific to DiaMedica Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?